Pomegranate juice can inhibit the metastasis of prostate cancer cells

Some components contained in pomegranate juice can resist the proliferation of prostate cancer cells, promote their apoptosis, and inhibit their metastasis.

Prostate cancer cells need testosterone to grow, and currently the usual method of inhibiting testosterone secretion is to prevent prostate cancer metastasis. However, this treatment is only effective in the early stages. Over time, cancer cells will develop resistance and quickly metastasize to the bone marrow, lungs, lymph nodes, and other parts. Researchers used pomegranate juice to treat prostate cancer cells that were resistant to the above treatment and found that the cancer cell death rate increased, and those cancer cells that did not die had stronger adhesion, which means that their ability to metastasize to other parts decreased.

Pomegranate is a fruit rich in antioxidants. After analyzing pomegranate juice, the effective anti-cancer ingredients it contains were identified, including phenylpropanoid compounds, hydroxybenzoic acid, flavonoids and conjugated fatty acids. These chemical components can enhance the adhesion of prostate cancer cells through molecular effects and curb the metastasis of cancer cells.

Pomegranate juice, a deep red beverage, has become increasingly popular as a health drink. The juice contains antioxidants, which fight damage to cells and chemicals that cause cancer and other diseases. Therefore, men with prostate cancer who are undergoing initial treatment may benefit from drinking a glass of pomegranate juice every day.